{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:51:37Z","timestamp":1793159497377,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006636","name":"Forskningsr\u00e5det om H\u00e4lsa, Arbetsliv och V\u00e4lf\u00e4rd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006636","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007949","name":"Reumatikerf\u00f6rbundet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007857","name":"Stiftelsen Konung Gustaf V:s 80-\u00e5rsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002706","name":"AFA F\u00f6rs\u00e4kring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002706","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sweden's Innovation Agency"},{"DOI":"10.13039\/501100001858","name":"VINNOVA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004785","name":"NordForsk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011727","name":"Stockholm l\u00e4ns landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001729","name":"Stiftelsen f\u00f6r Strategisk Forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovationsfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Federal Ministry of Education and Research in Germany","id":[{"id":"https:\/\/ror.org\/04pz7b180","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1136\/ard-2023-224728","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T05:08:58Z","timestamp":1701061738000},"page":"277-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8492-4045","authenticated-orcid":false,"given":"Eleftheria","family":"Pertsinidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saedis","family":"Saevarsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek Anand","family":"Manivel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9601-6186","authenticated-orcid":false,"given":"Lars","family":"Klareskog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Alfredsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Mathsson-Alm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7981-0927","authenticated-orcid":false,"given":"Martin","family":"Cornillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Serre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4969-2576","authenticated-orcid":false,"given":"Rikard","family":"Holmdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5415-270X","authenticated-orcid":false,"given":"Karl","family":"Skriner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per-Johan","family":"Jakobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3380-5342","authenticated-orcid":false,"given":"Helga","family":"Westerlind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0433-0616","authenticated-orcid":false,"given":"Johan","family":"Askling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1186-3226","authenticated-orcid":false,"given":"Johan","family":"R\u00f6nnelid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard-2023-224728_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0950-3579(97)80031-3","article-title":"Can we predict aggressive disease","volume":"11","author":"Young","year":"1997","journal-title":"Baillieres Clin Rheumatol"},{"key":"10.1136\/ard-2023-224728_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/728610","article-title":"The role of citrullinated protein antibodies in predicting erosive disease in rheumatoid arthritis: a systematic literature review and meta-analysis","volume":"2015","author":"Jilani","year":"2015","journal-title":"Int J Rheumatol"},{"key":"10.1136\/ard-2023-224728_bib3","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/ard.2004.033571","article-title":"Longitudinal analysis of citrullinated protein\/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression","volume":"64","author":"R\u00f6nnelid","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224728_bib4","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.3899\/jrheum.140082","article-title":"Prognosis of seronegative patients in a large prospective cohort of patients with early inflammatory arthritis","volume":"41","author":"Barra","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2023-224728_bib5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/annrheumdis-2015-208873","article-title":"Patients with seronegative RA have more inflammatory activity compared with patients with Seropositive RA in an inception cohort of DMARD-naive patients classified according to the 2010 ACR\/EULAR criteria","volume":"76","author":"Nordberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224728_bib6","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-015-0736-9","article-title":"Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials","volume":"17","author":"Aletaha","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard-2023-224728_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of Antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1136\/ard-2023-224728_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/annrheumdis-2017-211782","article-title":"Anticitrullinated protein\/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants","volume":"77","author":"R\u00f6nnelid","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224728_bib9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","article-title":"A new model for an etiology of RA; smoking may trigger HLA-DR (SE) - restricted immune reactions to autoantigens modified by citrullination","volume":"54","author":"Klareskog","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-224728_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-224728_bib11","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1136\/ard.2004.031666","article-title":"Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study","volume":"64","author":"Bengtsson","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224728_bib12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3109\/03009740903501634","article-title":"Non-participation in EIRA: a population-based case-control study of rheumatoid arthritis","volume":"39","author":"Bengtsson","year":"2010","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard-2023-224728_bib13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/03009748809098795","article-title":"Assessing disability in patients with rheumatoid arthritis. use of a Swedish version of the Stanford health assessment questionnaire","volume":"17","author":"Ekdahl","year":"1988","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard-2023-224728_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-224728_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/ar4039","article-title":"Validation of a Multiplex chip-based for the detection of Autoantibodies against Citrullinated peptides","volume":"14","author":"Hansson","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard-2023-224728_bib16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1084\/jem.20081862","article-title":"Structure and Pathogenicity of antibodies specific for Citrullinated collagen type II in experimental arthritis","volume":"206","author":"Uysal","year":"2009","journal-title":"J Exp Med"},{"key":"10.1136\/ard-2023-224728_bib17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.55563\/clinexprheumatol\/4bcmdb","article-title":"Rheumatoid arthritis autoantibodies and their association with age and sex","volume":"39","author":"Pertsinidou","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard-2023-224728_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10067-003-0844-9","article-title":"Young age of onset is associated with increased prevalence of circulating Igm rheumatoid factor and antinuclear antibodies at presentation in women with rheumatoid arthritis","volume":"23","author":"Jacobsen","year":"2004","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard-2023-224728_bib19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/03009742.2017.1416668","article-title":"Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy","volume":"47","author":"Fedele","year":"2018","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard-2023-224728_bib20","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/art.37835","article-title":"Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis","volume":"65","author":"Brink","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-224728_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clim.2018.05.004","article-title":"Combination of anti-citrullinated protein antibodies and rheumatoid factor is associated with increased systemic inflammatory mediators and more rapid progression from Preclinical to clinical rheumatoid arthritis","volume":"195","author":"Lingampalli","year":"2018","journal-title":"Clin Immunol"},{"key":"10.1136\/ard-2023-224728_bib22","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/art.23284","article-title":"Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to Citrullinated proteins Complexed with fibrinogen","volume":"58","author":"Clavel","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-224728_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/art.30081","article-title":"Immune complexes containing citrullinated fibrinogen costimulate Macrophages via toll-like receptor 4 And Fcgamma receptor","volume":"63","author":"Sokolove","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-224728_bib24","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/art.38307","article-title":"Rheumatoid factor as a potentiator of anti-citrullinated protein antibody-mediated inflammation in rheumatoid arthritis","volume":"66","author":"Sokolove","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2023-224728_bib25","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1136\/annrheumdis-2013-204543","article-title":"Igm rheumatoid factor amplifies the inflammatory response of Macrophages induced by the rheumatoid arthritis-specific immune complexes containing Anticitrullinated protein antibodies","volume":"74","author":"Laurent","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224728_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13075-016-0940-2","article-title":"Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and Carbamylated proteins before the onset of rheumatoid arthritis","volume":"18","author":"Brink","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard-2023-224728_bib27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13075-021-02556-1","article-title":"Plasma interferon-alpha is associated with double-positivity for Autoantibodies but is not a Predictor of remission in early rheumatoid arthritis-a spin-off study of the NORD-STAR randomized clinical trial","volume":"23","author":"Stockfelt","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard-2023-224728_bib28","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1513\/AnnalsATS.202006-590OC","article-title":"Autoantibody seropositivity and risk for interstitial lung disease in a prospective male-predominant rheumatoid arthritis cohort of U.S","volume":"18","author":"Natalini","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"10.1136\/ard-2023-224728_bib29","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1136\/annrheumdis-2016-210873","article-title":"Anti-collagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and Prognosticate lower degree of inflammation during five years follow-up","volume":"76","author":"Manivel","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224728_bib30","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/s41423-020-0381-3","article-title":"Therapeutic ACPA inhibits NET formation: a potential therapy for neutrophil-mediated inflammatory diseases","volume":"18","author":"Chirivi","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1136\/ard-2023-224728_bib31","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41467-023-36257-x","article-title":"A subset of antibodies targeting citrullinated proteins confers protection from rheumatoid arthritis","volume":"14","author":"He","year":"2023","journal-title":"Nat Commun"},{"key":"10.1136\/ard-2023-224728_bib32","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/ard-2022-223417","article-title":"Divergent and dominant anti-inflammatory effects of patient-derived Anticitrullinated protein antibodies (ACPA) in arthritis development","volume":"82","author":"Raposo","year":"2023","journal-title":"Ann Rheum Dis"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672400356X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672400356X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard-2023-224728","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T03:19:10Z","timestamp":1739503150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672400356X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S000349672400356X"],"URL":"https:\/\/doi.org\/10.1136\/ard-2023-224728","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard-2023-224728","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 \u00a9 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}